Structures by: Fraser H. L.
Total: 5
5-Methyl-5bβ,6,7,8,9,11aα-hexahydro-5H-indolizino[1,2-b]indol-11(5aαH)-one
C15H18N2O
Acta Crystallographica Section E (2007) 63, 1 o349-o350
a=8.008(2)Å b=17.862(4)Å c=8.888(3)Å
α=90° β=94.53(3)° γ=90°
1-(2-Bromo-1-methylindol-3-ylcarbonyl)pyrrolidine
C14H15BrN2O
Acta Crystallographica Section E (2007) 63, 5 o2474-o2475
a=7.327(2)Å b=9.387(3)Å c=10.412(4)Å
α=96.14(3)° β=100.94(3)° γ=109.32(3)°
1-(2-Bromo-1-methylindol-3-ylcarbonyl)piperidine
C15H17BrN2O
Acta Crystallographica Section E (2007) 63, 5 o2476-o2477
a=7.819(3)Å b=8.218(3)Å c=11.114(5)Å
α=69.99(3)° β=91.21(4)° γ=111.16(3)°
Azepinyl 2-bromo-1-methyl-1H-indol-3-yl ketone
C16H19BrN2O
Acta Crystallographica Section E (2007) 63, 5 o2480-o2481
a=6.9348(9)Å b=10.7030(19)Å c=10.882(3)Å
α=108.384(17)° β=97.601(16)° γ=100.395(13)°
2-Bromo-N-tert-butyl-N,1-dimethyl-1H-indole-3-carboxamide
C15H19BrN2O
Acta Crystallographica Section E (2007) 63, 5 o2478-o2479
a=7.373(7)Å b=21.453(7)Å c=9.132(9)Å
α=90.00° β=96.06(9)° γ=90.00°